MedTrace Logo

Chronic Myeloid Leukemia (CML) Real-Life Database

NCT05963061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2024-04-09

No results posted yet for this study

Summary

Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.

Conditions

  • Chronic Myeloid Leukemia (CML)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    collaborator OTHER

  • Bicetre Hospital

    collaborator OTHER

  • University Hospital, Caen

    collaborator OTHER

  • Central Hospital, Nancy, France

    collaborator OTHER

  • University Hospital, Toulouse

    collaborator OTHER

  • CH Annecy Genevois

    collaborator OTHER

  • Rennes University Hospital

    collaborator OTHER

  • Hopital Paul Brousse

    collaborator OTHER

  • Versailles Hospital

    collaborator OTHER

  • Centre Hospitalier Emile Roux

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • Institut Paoli-Calmettes

    collaborator OTHER

  • Centre Hospitalier de Rochefort

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Marc BERGER, MD · University Hospital, Clermont-Ferrand

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-16
Primary Completion
2034-04-16
Completion
2034-04-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05963061 on ClinicalTrials.gov